0001104659-18-030636.txt : 20180504
0001104659-18-030636.hdr.sgml : 20180504
20180504160657
ACCESSION NUMBER: 0001104659-18-030636
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180502
FILED AS OF DATE: 20180504
DATE AS OF CHANGE: 20180504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rowland Charles A Jr
CENTRAL INDEX KEY: 0001383292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 18807940
MAIL ADDRESS:
STREET 1: 3338 LANCASHIRE RD
CITY: FURLONG
STATE: PA
ZIP: 18925
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2018-05-02
0
0001641640
Nabriva Therapeutics plc
NBRV
0001383292
Rowland Charles A Jr
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
1
0
0
0
Stock Option
2018-05-02
4
A
0
29000
0.00
A
2028-05-02
Ordinary Shares
29000
29000
D
The exercise price is $4.91 per share.
This option was granted on May 2, 2018. Vesting began on May 2, 2018 and ends on May 2, 2019. One hundred percent (100%) of the option will vest on May 2, 2019.
/s/ Robert Crotty, by power of attorney
2018-05-04